Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall…
Read more Wells Fargo CEO talks up reasons to love the stock — plus, what’s behind the market dropWhen stocks are in steep uptrends, it can difficult be difficult to determine when a meaningful corrective move is going to take place. We all want to capture…
Read more Time to sell Nvidia? How to trade stocks that have ‘gone parabolic’Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Friday’s key moments. 1. U.S. stocks…
Read more One of our financial stocks hit a new high: Here’s why we’re eyeing a small tradeShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Closing Bell: Overtime Barbara Doran, BD8 Capital CEO and Brooke May, Evans May Wealth managing…
Read more Hesitant to buy bank stocks long-term over lingering regulatory issues: wealth advisor Brooke MayCNBC’s Jim Cramer on Friday told investors what to watch for on Wall Street next week, highlighting JPMorgan‘s market-moving health-care conference in San Francisco. Taking place from Monday…
Read more Cramer's week ahead: Earnings season kicks off after JPMorgan Healthcare ConferencePfizer on Friday said it would stop developing the twice-daily version of its experimental weight loss pill after obese patients taking the drug lost significant weight but had…
Read more Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effectsGame-changing anti-obesity medications have posed nothing short of an existential crisis for Weight Watchers parent WW International since they arrived on the scene, but CEO Sima Sistani has…
Read more The Ozempic effect has battered this weight loss stock, but Morgan Stanley says it’s a top pickThe top 10 things to watch Friday, Oct. 20 1. Will the yield on the 10-year Treasury breach 5% Friday, and how will markets react? U.S. stocks are…
Read more The top 10 things to watch in the stock market FridayTwo experts see major challenges facing the adoption of new obesity drugs. Dr. Kavita Patel, a physician and NBC News medical contributor, believes fresh data from Novo Nordisk…
Read more ‘Miracle drug’ euphoria: Experts warn widespread use of weight loss medicine faces major hurdlesMcCormick spices are displayed on a shelf at a supermarket on March 28, 2023 in San Anselmo, California. Spice Maker McCormick reported better-than-expected first quarter earnings with revenues…
Read more Stocks making the biggest moves midday: Meta, Warby Parker, McCormick and moreJim Cramer ran through all 35 Club stocks during our September Monthly Meeting on Thursday. Source link
Read more Here’s a rapid-fire update on all 35 stocks in the Club’s portfolio, including a new buyWeight loss drugs are being assessed for their ability to treat conditions like dementia and addiction after a landmark study showed that Wegovy helped reduce the risk of…
Read more Blockbuster weight loss drugs Wegovy and Ozempic are being tested to treat addiction and dementiaMarket Movers rounded up the best reactions from investors and analysts on Eli Lilly . The experts, including Jim Cramer , discussed the drugmaker after it reported second-quarter…
Read more Eli Lilly hits record high after earnings, Mounjaro hype. Here’s what the pros are sayingEvery weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Tuesday’s key moments. Stocks sink Eli…
Read more Here’s what is behind the stock market’s selloff and what we’re doing about itEvery weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Tuesday’s key moments. Watch Morgan Stanley…
Read more A key bank stock soars, but Cramer sticks to his disciplineTraders work on the floor of the New York Stock Exchange during morning trading, April 10, 2023. Michael M. Santiago | Getty Images The pharmaceutical industry’s largest lobbying…
Read more Pharmaceutical trade group sues Biden administration over Medicare drug price negotiationsYou can’t deny the buzz. Credit Suisse analyst Trung Huynh has combed through social media and is impressed by the awareness — and demand — for GLP-1 medications…
Read more Credit Suisse sees Eli Lilly headed higher as Mounjaro users espouse weight loss drug on social mediaAn Eli Lilly and Company pharmaceutical manufacturing plant is pictured at 50 ImClone Drive in Branchburg, New Jersey, March 5, 2021. Mike Segar | Reuters The Alzheimer’s treatment…
Read more Eli Lilly Alzheimer’s treatment donanemab slowed disease progression in clinical trialJuanmonino | E+ | Getty Images Seniors with early Alzheimer’s disease will face major hurdles to get treated even if promising new drugs roll out more broadly in…
Read more Alzheimer’s patients may wait years to get treated with new drugs, putting them at risk of more severe diseaseJohn Zich | Bloomberg | Getty Images U.S. Treasury yields were little changed on Tuesday, as investors continued to assess the outlook for the U.S. economy and digested…
Read more Treasury yields little changed as focus remains on economic outlook, earnings
